Enhancement of megakaryocytopoiesis by Campath-1G-treated natural killer cells

Nagler, A; Condiotti, R; Lubina, A; Deutsch, V R
October 1997
Bone Marrow Transplantation;10/1/97, Vol. 20 Issue 7, p525
Academic Journal
Campath-1G is a CD52 (rat IgG2b) moAb used in bone marrow transplantation (BMT) to prevent graft-versus-host disease (GVHD) by the elimination of T cells via antibody-dependent cell cytotoxicity (ADCC) in vivo. We have previously reported that Campath-1G induces T cell proliferation, activation, and production of cytokines which in turn causes an enhancement of megakaryocytopoiesis in vitro. In view of the fact that recent studies have indicated that natural killer (NK) cells may also be involved in the regulation of megakaryocytopoiesis, we undertook the study of the in vitro effect of Campath-1G-treated NK cells on the regulation of megakaryocytopoiesis. Early burst-forming BFU-MK and late colony-forming CFU-MK were grown from 2 × 105 peripheral blood non-adherent mononuclear cells (NAMC) in plasma clots in the presence of aplastic canine plasma (PICS-J) which was used as megakaryocyte colony-stimulating factor (MK-CSF). The first step in elucidating this series of events was to investigate the direct influence of NK cells on megakaryocytopoiesis. Co-culturing NK cells (>85% CD16+) with autologous NAMC at a ratio of 1:1 resulted in a significant increase in the proliferation of CFU-MK and BFU-MK over NAMC cultured alone. This effect was further enhanced upon exposure of NK to Campath-1G (0.1–3 μ g/ml). To investigate the possible influence of soluble factors released from NK cells treated with Campath-1G on MK maturation, conditioned medium (CM) derived from Campath-1G-treated-enriched populations of NK cells was found to enhance MK progenitor growth. Our data demonstrate that resting and Campath-1G-treated NK may be involved in the immunomodulation of megakaryocytopoiesis.


Related Articles

  • NK cells.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1589 

    An encyclopedia entry for "NK cells," which refers to natural killer cells, is presented.

  • Selective antitumor activity of lymphokine-activated killer cells in vitro. O. Zhukova; O. Lebedinskaya; I. Shubina; G. Gerasimova; A. Karamzin; M. Kiselevskii // Bulletin of Experimental Biology & Medicine;Jan2007, Vol. 143 Issue 1, p132 

    Abstract  We compared cytotoxic activity of blood mononuclear leukocytes from healthy donors and lymphokine-activated killer cells generated from them towards tumor and normal cells. Lymphokine-activated killer cells exhibited higher (in comparison with blood mononuclear leukocytes) killer...

  • IL-15 may Attract PB CD16- NK Cells into the Endometrium. Perloe, Mark; Key, S.; Mitchell, J.; Holcomb, K.; Shepherd, Joy // Fertility Weekly;7/11/2005, p6 

    Reports on a study which found that the rise of endometrial CD16(-) natural killer (NK) cells that occurs after ovulation may be caused by endogenous IL-15 in secretory phase endometrium. Postovulatory rise in endometrial CD16(-) NK cells.

  • Examination of NK Receptors on Human Decidual Leukocytes. Christmas, Stephen E. // Fertility Weekly;11/4/2002, p11 

    Cites a study conducted by Barry J. Lewis and colleagues in Great Britain, which undertakes detailed analysis of the expression of natural killer (NK) cell activatory and inhibitory receptors by human decidual leukocyte subpopulations. Higher proportion of T cells in decidua than in peripheral...

  • Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways. Junko Sawaki; Hiroko Tsutsui; Nobuki Hayashi; Koubun Yasuda; Shizuo Akira; Takakuni Tanizawa; Kenji Nakanishi // International Immunology;Mar2007, Vol. 19 Issue 3, p311 

    It is well established that IL-18R- and toll-like receptor (TLR)-mediated signalings share a common signal pathway mediated by signal adaptor, MyD88, and that IL-18 synergizes with IL-12 for IFN-γ production by NK cells. Here, we investigated whether TLR agonists can replace IL-18 for...

  • Natural Killer Cells.  // Encyclopedic Reference of Molecular Pharmacology;2004, p625 

    An encyclopedia entry for "natural killer cells" is presented. They refer to large granular lymphocytes and are considered as part of the innate defense system. They are able to kill certain tumor cells without prior sensitization. Their basal activity increases following stimulation with type I...

  • Cancer-killing cells are caught on film in more 3-D detail than ever before.  // Biomedical Market Newsletter;9/26/2011, Vol. 21, p610 

    The article reports that scientists from Imperial College London reveal on film how the natural cancer-killing cells in the white blood called Natural Killer cells are protecting the body from tumors and other virus-infections.

  • Genotype of KIR2DL4 Affects INFγ Secretion.  // Fertility Weekly;9/21/2009, p5 

    The article presents the study by J.P. Goodridge and colleagues which examined the effect of genotype of killer immunoglobulin-like receptor (KIR) KIR2DL4 on interferon gamma (IFNγ) secretion by decidual NK (dNK) cells in Australia. The study aimed at analyzing the KIR2DL4 expression and...

  • Significance of chemokine receptor expression in aggressive NK cell leukemia. Makishima, H.; Ito, T.; Asano, N.; Nakazawa, H.; Shimodaira, S.; Kamijo, Y.; Nakazawa, Y.; Suzuki, T.; Kobayashi, H.; Kiyosawa, K.; Ishida, F. // Leukemia (08876924);Jul2005, Vol. 19 Issue 7, p1169 

    Natural killer (NK) cell-type lymphoproliferative diseases of granular lymphocytes can be subdivided into aggressive NK cell leukemia (ANKL) and chronic NK cell lymphocytosis (CNKL). One reason for the poor outcome in ANKL is leukemic infiltration into multiple organs. The mechanisms of cell...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics